Overview
This educational guide combines two research peptides frequently studied together for their potential synergistic effects on growth hormone (GH) release. The stack pairs a long-acting GHRH analog with a selective GH secretagogue.
Composition
CJC-1295 DAC (5mg Vial)
– Long-acting growth hormone-releasing hormone analog
– Extended GH release capability
– Increases IGF-1 levels over time
Ipamorelin (5mg Vial)
– Selective growth hormone secretagogue
– Triggers GH release without significantly affecting cortisol or prolactin
– Complementary mechanism to CJC-1295 DAC
Reconstitution Guide
CJC-1295 DAC — Standard Approach
1. Draw 2.0 mL of bacteriostatic water into a sterile syringe
2. Inject slowly along the vial wall to minimize foam formation
3. Gently swirl — avoid vigorous shaking
4. Store at 2–8°C, protected from light
Result: 2.5 mg/mL concentration
CJC-1295 DAC — Advanced Approach
1. Draw 1.0 mL of bacteriostatic water
2. Inject slowly along vial wall; gently swirl until dissolved
3. Refrigerate at 2–8°C, protected from light
Result: 5 mg/mL concentration
Ipamorelin — Standard Approach
1. Draw 3.0 mL of bacteriostatic water
2. Inject slowly along vial wall; gently swirl until dissolved
3. Store at 2–8°C, protected from light
Result: ~1.67 mg/mL concentration
Ipamorelin — Advanced Approach
1. Draw 1.0 mL of bacteriostatic water
2. Inject slowly; swirl gently until dissolved
3. Store at 2–8°C, protected from light
Result: 5 mg/mL concentration
Dosage Protocols
CJC-1295 DAC — Standard Protocol
| Week | Weekly Total | Per Injection | Volume (mL) | Frequency |
|---|---|---|---|---|
| 1–4 | 1–2 mg/week | 0.5–1 mg | ~0.2–0.4 mL | 1–2× per week |
CJC-1295 DAC — Advanced Protocol
| Week | Weekly Total | Per Injection | Volume (mL) | Frequency |
|---|---|---|---|---|
| 1–4 | 3 mg/week | ~1 mg | ~0.2 mL | 3× per week |
Ipamorelin — Standard Protocol
| Week | Daily Total | Per Injection | Volume (mL) | Frequency |
|---|---|---|---|---|
| 1–4 | 300–500 mcg/day | 300–500 mcg | ~0.18–0.3 mL | 1× daily |
Ipamorelin — Advanced Protocol
| Week | Daily Total | Per Injection | Volume (mL) | Frequency |
|---|---|---|---|---|
| 1–4 | 600–700 mcg/day | ~300–350 mcg | ~0.06–0.07 mL | 2× daily |
Combined Stack Protocol
– CJC-1295 DAC: 1–2 mg weekly (standard) or up to 3 mg weekly (advanced)
– Ipamorelin: 300–700 mcg daily, split into 1–3 daily injections
– Cycle length: 4–8 weeks; some extend to 12 weeks with periodic breaks
– Reconstitute each peptide separately — never combine in the same syringe
Administration Schedule
– CJC-1295 DAC timing: Once or twice weekly (standard); up to 3× weekly (advanced)
– Ipamorelin timing: 1–3 daily injections
– No strict timing requirement between the two peptides
– Rotate injection sites between abdomen, thighs, and deltoids
Storage
Lyophilized vials: Store at 2–8°C until reconstitution; protect from light
Reconstituted solutions:
– Maintain refrigeration at 2–8°C
– Use within 14–28 days of reconstitution
– Avoid repeated freeze-thaw cycles
How This Stack Works
CJC-1295 DAC: Extends GH release through GHRH analog activity, stimulating sustained GH secretion and increasing IGF-1 levels over time.
Ipamorelin: Triggers acute GH pulses via selective GH secretagogue activity without significantly elevating cortisol or prolactin.
Synergistic effect: Stacking provides a more sustained GH pulse (from CJC-1295 DAC) combined with consistent GH peaks (from Ipamorelin).
Potential Benefits
– Support for muscle tissue repair and recovery
– Potential benefits for injury recovery mechanisms
– Enhanced collagen synthesis support
– Consistent GH and IGF-1 elevation
Possible Side Effects
– Injection site irritation or mild discomfort
– Water retention
– Headaches
Important Considerations
– Use new sterile insulin syringes for each injection
– Rotate injection sites regularly to minimize tissue irritation
– Never combine CJC-1295 DAC and Ipamorelin in the same syringe
– Monitor for adverse reactions; consult a professional if concerns arise
– Keep injection volumes between ~10–60 units when possible for accuracy
Lifestyle Factors
– Maintain balanced diet with adequate protein intake
– Stay hydrated throughout the protocol
– Engage in regular exercise with proper rest and recovery
– Prioritize quality sleep
– Manage stress effectively
Disclaimer
This guide is for educational and research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any research protocol.